CN104958813A - 无针注射器和优化注射性能的无针注射器设计参数 - Google Patents
无针注射器和优化注射性能的无针注射器设计参数 Download PDFInfo
- Publication number
- CN104958813A CN104958813A CN201510167794.5A CN201510167794A CN104958813A CN 104958813 A CN104958813 A CN 104958813A CN 201510167794 A CN201510167794 A CN 201510167794A CN 104958813 A CN104958813 A CN 104958813A
- Authority
- CN
- China
- Prior art keywords
- pressure
- delivery
- syringe
- needleless injector
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002347 injection Methods 0.000 title claims abstract description 109
- 239000007924 injection Substances 0.000 title claims abstract description 109
- 238000013461 design Methods 0.000 title description 10
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 238000002360 preparation method Methods 0.000 claims description 78
- 239000003814 drug Substances 0.000 claims description 66
- 239000007788 liquid Substances 0.000 claims description 49
- 229940079593 drug Drugs 0.000 claims description 27
- 238000010276 construction Methods 0.000 claims description 23
- 238000009826 distribution Methods 0.000 claims description 16
- 230000035515 penetration Effects 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- -1 antifungal Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 208000019695 Migraine disease Diseases 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 3
- 229960000074 biopharmaceutical Drugs 0.000 claims description 3
- 206010027599 migraine Diseases 0.000 claims description 3
- 238000009527 percussion Methods 0.000 claims description 3
- 238000007920 subcutaneous administration Methods 0.000 claims description 3
- 229960005486 vaccine Drugs 0.000 claims description 3
- 206010003645 Atopy Diseases 0.000 claims description 2
- 102000018997 Growth Hormone Human genes 0.000 claims description 2
- 108010051696 Growth Hormone Proteins 0.000 claims description 2
- 206010021928 Infertility female Diseases 0.000 claims description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 2
- 102000006992 Interferon-alpha Human genes 0.000 claims description 2
- 108010047761 Interferon-alpha Proteins 0.000 claims description 2
- 208000001132 Osteoporosis Diseases 0.000 claims description 2
- 208000028017 Psychotic disease Diseases 0.000 claims description 2
- 102000013275 Somatomedins Human genes 0.000 claims description 2
- 230000000202 analgesic effect Effects 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 229940127003 anti-diabetic drug Drugs 0.000 claims description 2
- 230000000843 anti-fungal effect Effects 0.000 claims description 2
- 230000001387 anti-histamine Effects 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 230000002141 anti-parasite Effects 0.000 claims description 2
- 230000000767 anti-ulcer Effects 0.000 claims description 2
- 239000003472 antidiabetic agent Substances 0.000 claims description 2
- 229940121375 antifungal agent Drugs 0.000 claims description 2
- 239000000739 antihistaminic agent Substances 0.000 claims description 2
- 229940034982 antineoplastic agent Drugs 0.000 claims description 2
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 239000003096 antiparasitic agent Substances 0.000 claims description 2
- 239000003443 antiviral agent Substances 0.000 claims description 2
- 230000002917 arthritic effect Effects 0.000 claims description 2
- 206010003246 arthritis Diseases 0.000 claims description 2
- 229940124630 bronchodilator Drugs 0.000 claims description 2
- 239000002327 cardiovascular agent Substances 0.000 claims description 2
- 229940125692 cardiovascular agent Drugs 0.000 claims description 2
- 229940125693 central nervous system agent Drugs 0.000 claims description 2
- 239000003576 central nervous system agent Substances 0.000 claims description 2
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 claims description 2
- 229960001076 chlorpromazine Drugs 0.000 claims description 2
- 238000013270 controlled release Methods 0.000 claims description 2
- 230000035558 fertility Effects 0.000 claims description 2
- 239000000122 growth hormone Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 238000007918 intramuscular administration Methods 0.000 claims description 2
- 229940124549 vasodilator Drugs 0.000 claims description 2
- 239000003071 vasodilator agent Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 49
- 238000009472 formulation Methods 0.000 abstract description 14
- 239000012669 liquid formulation Substances 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 28
- 210000003491 skin Anatomy 0.000 description 23
- 239000000463 material Substances 0.000 description 18
- 239000003708 ampul Substances 0.000 description 12
- 230000008859 change Effects 0.000 description 11
- 230000000149 penetrating effect Effects 0.000 description 11
- 238000000338 in vitro Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 210000002615 epidermis Anatomy 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 8
- 239000004810 polytetrafluoroethylene Substances 0.000 description 8
- 239000008186 active pharmaceutical agent Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 230000000007 visual effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 206010011409 Cross infection Diseases 0.000 description 5
- 206010029803 Nosocomial infection Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 238000010254 subcutaneous injection Methods 0.000 description 5
- 239000007929 subcutaneous injection Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 208000012266 Needlestick injury Diseases 0.000 description 4
- 238000010255 intramuscular injection Methods 0.000 description 4
- 239000007927 intramuscular injection Substances 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010034912 Phobia Diseases 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 239000008177 pharmaceutical agent Substances 0.000 description 3
- 208000019899 phobic disease Diseases 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940088679 drug related substance Drugs 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 229950000845 politef Drugs 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 241001504639 Alcedo atthis Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000011982 device technology Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940090046 jet injector Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 229960004616 medroxyprogesterone Drugs 0.000 description 1
- FRQMUZJSZHZSGN-HBNHAYAOSA-N medroxyprogesterone Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](O)(C(C)=O)CC[C@H]21 FRQMUZJSZHZSGN-HBNHAYAOSA-N 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229940071643 prefilled syringe Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A61M5/3007—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules with specially designed jet passages at the injector's distal end
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38320510P | 2010-09-15 | 2010-09-15 | |
| US61/383,205 | 2010-09-15 | ||
| CN201180044022.2A CN103153370B (zh) | 2010-09-15 | 2011-09-14 | 无针注射器和优化注射性能的无针注射器设计参数 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201180044022.2A Division CN103153370B (zh) | 2010-09-15 | 2011-09-14 | 无针注射器和优化注射性能的无针注射器设计参数 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104958813A true CN104958813A (zh) | 2015-10-07 |
Family
ID=45807406
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510167794.5A Pending CN104958813A (zh) | 2010-09-15 | 2011-09-14 | 无针注射器和优化注射性能的无针注射器设计参数 |
| CN201180044022.2A Expired - Fee Related CN103153370B (zh) | 2010-09-15 | 2011-09-14 | 无针注射器和优化注射性能的无针注射器设计参数 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201180044022.2A Expired - Fee Related CN103153370B (zh) | 2010-09-15 | 2011-09-14 | 无针注射器和优化注射性能的无针注射器设计参数 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8734384B2 (https=) |
| EP (1) | EP2616123A4 (https=) |
| JP (2) | JP5856621B2 (https=) |
| CN (2) | CN104958813A (https=) |
| AU (1) | AU2011302072B2 (https=) |
| CA (1) | CA2810078A1 (https=) |
| WO (1) | WO2012037268A2 (https=) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105448172A (zh) * | 2015-12-30 | 2016-03-30 | 天津天堰科技股份有限公司 | 教学用模拟注射器 |
| CN110292684A (zh) * | 2019-08-09 | 2019-10-01 | 江苏丞宇米特医疗科技有限公司 | 一次装药多次注射双压力无针注射器 |
| CN113318301A (zh) * | 2021-06-28 | 2021-08-31 | 北京科技大学 | 一种大剂量多孔无针注射器 |
| CN115068747A (zh) * | 2022-07-21 | 2022-09-20 | 汤小彬 | 一种气压式无针注射手柄 |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9108026B2 (en) * | 2009-07-09 | 2015-08-18 | Cook Medical Technologies Llc | Spring action medical device |
| US8734384B2 (en) * | 2010-09-15 | 2014-05-27 | Zogenix, Inc. | Needle-free injectors and design parameters thereof that optimize injection performance |
| EP2732770B1 (de) * | 2012-11-16 | 2016-08-24 | Erbe Elektromedizin GmbH | Nadellose Injektionsvorrichtung |
| WO2014093818A2 (en) * | 2012-12-14 | 2014-06-19 | Bioject, Inc. | Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men |
| CN103323174B (zh) * | 2013-06-09 | 2015-02-11 | 东南大学 | 一种无针注射射流压力的测量装置的测量方法 |
| KR102320331B1 (ko) * | 2013-08-27 | 2021-11-03 | 레프로-메드 시스템즈, 인코포레이티드 | 피하 치료를 위한 바늘을 선택하는 방법 |
| CN105413024A (zh) * | 2016-01-07 | 2016-03-23 | 深圳市赫拉铂氢时代科技有限公司 | 纳米/微米氢水无针注射仪及其注射方法 |
| US9724473B2 (en) * | 2016-01-12 | 2017-08-08 | Nickolas Peter Demas | Multi-directional low-displacement force sensor |
| ES2814287T3 (es) * | 2016-03-15 | 2021-03-26 | Amgen Inc | Reducir la probabilidad de rotura de cristal en dispositivos de administración de fármaco |
| US10251964B2 (en) | 2016-08-23 | 2019-04-09 | Drma Group International Llc | Self-disinfecting needleless device |
| US10195110B2 (en) | 2016-09-08 | 2019-02-05 | Drma Group International Llc | Capping device for disinfecting medical container |
| US10391294B2 (en) | 2016-09-12 | 2019-08-27 | Drma Group International Llc | Disinfecting cap |
| US10610676B2 (en) | 2016-09-26 | 2020-04-07 | Drma Group International Llc | Disinfecting luer connector |
| US10182968B2 (en) | 2017-03-06 | 2019-01-22 | Drma Group International Llc | Disinfecting capping device for sharp medical objects |
| JP7329307B2 (ja) * | 2017-06-27 | 2023-08-18 | 株式会社ダイセル | 無針注射器の製造方法、無針注射器における点火薬及びガス発生剤の量を設定する方法、および無針注射器の射出パラメータ算出プログラム |
| US11541219B2 (en) | 2017-07-10 | 2023-01-03 | Drma Group International Llc | Capping device for disinfecting medical injection membranes |
| FR3078489B1 (fr) | 2018-03-01 | 2025-06-27 | Oreal | Cartouche pour dispositif d'injection sans aiguille |
| FR3082712B1 (fr) | 2018-06-26 | 2020-07-31 | Oreal | Systeme d'injection sans aiguille |
| CN112534274B (zh) * | 2018-07-25 | 2023-10-13 | 株式会社大赛璐 | 测定系统、测定方法、注入器、以及使用该注入器向注入对象的细胞内注入包含生物分子的溶液的注入方法 |
| CN112336949A (zh) * | 2019-08-08 | 2021-02-09 | 武汉大学 | 一种气动式无针注射驱动气压切换装置及其使用方法 |
| WO2021089163A1 (en) | 2019-11-07 | 2021-05-14 | L'oreal | Needleless injection device for in-situ reaction |
| JP2021095353A (ja) | 2019-12-16 | 2021-06-24 | ロレアル | ヒアルロン酸の液滴を使用する美容方法 |
| US11752269B2 (en) | 2019-12-18 | 2023-09-12 | Integrimedical Llc | Spring loaded medical needle-free injection system |
| FR3115692B1 (fr) | 2020-10-30 | 2024-03-01 | Oreal | Gouttelettes comprenant un composé non polymérique |
| CN112908468B (zh) * | 2021-01-23 | 2024-01-12 | 上海熙软科技有限公司 | 一种基于5g网络的智慧医疗管理系统 |
| CN117861021B (zh) * | 2024-02-27 | 2024-10-15 | 江苏乐聚医药科技有限公司 | 一次性药芯单次装药多次注射的无针注射器及其配置方法 |
| WO2025206737A1 (ko) * | 2024-03-26 | 2025-10-02 | 바즈바이오메딕 주식회사 | 무바늘 주사기 |
| WO2025206734A1 (ko) * | 2024-03-26 | 2025-10-02 | 바즈바이오메딕 주식회사 | 무바늘 주사기 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1399567A (zh) * | 1999-08-20 | 2003-02-26 | 生物项目股份有限公司 | 将dna为主剂的注射剂注入人体的皮内注射系统 |
| CN1681546A (zh) * | 2002-07-11 | 2005-10-12 | 特克法马许可公司 | 无针式注射装置 |
| US20080119783A1 (en) * | 2001-10-24 | 2008-05-22 | Zogenix, Inc. | Needleless injector |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3859996A (en) | 1973-07-18 | 1975-01-14 | Mizzy Inc | Multi-dose injector |
| US4421508A (en) | 1981-02-24 | 1983-12-20 | Cohen Edgar C | Vacuum-compression injector |
| DE3115376A1 (de) | 1981-04-16 | 1982-12-16 | Hoechst Ag, 6000 Frankfurt | Nadelloses injektionsgeraet |
| DE3115375A1 (de) | 1981-04-16 | 1982-11-11 | Hoechst Ag, 6000 Frankfurt | Kolbenpumpe fuer nadellose injektionsgeraete |
| HU186718B (en) | 1983-06-29 | 1985-09-30 | Radelkis Electrokemiai | Automatic needleless syringe operable by cardox cylinder suitable for personal giving injection e.g. insulin |
| US4913699A (en) | 1988-03-14 | 1990-04-03 | Parsons James S | Disposable needleless injection system |
| EP0347190A1 (en) | 1988-06-14 | 1989-12-20 | Vci Corporation | Needleless vacuum-compression injector |
| AU6550990A (en) | 1989-11-09 | 1991-05-16 | Bioject, Inc. | Needleless hypodermic injection device |
| WO1992008508A1 (en) | 1990-11-09 | 1992-05-29 | Sy-Quest International Limited | Needleless hypodermic jet injector device |
| GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
| US5383851A (en) * | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| CA2167586C (en) | 1993-07-31 | 2005-01-25 | Terence Edward Weston | Needle-less injector |
| GB9425642D0 (en) | 1994-12-20 | 1995-02-22 | Weston Medical Ltd | Filling device |
| GB9504878D0 (en) | 1995-03-10 | 1995-04-26 | Weston Medical Ltd | Viscously coupled actuator |
| GB9525757D0 (en) | 1995-12-16 | 1996-02-14 | Weston Medical Ltd | Needleless injector drug capsule and filling method |
| GB9602605D0 (en) | 1996-02-09 | 1996-04-10 | Weston Medical Ltd | Injection aid |
| JP3573431B2 (ja) | 1996-04-02 | 2004-10-06 | ウェストン メディカル リミテッド | 薬剤カプセルに充填する方法並びにそれによって製造される物品 |
| GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
| NL1004059C2 (nl) | 1996-09-18 | 1998-03-19 | Plastic Moulding Appliances B | Samenstel van houder en breeksluiting en werkwijze voor de vervaardiging daarvan. |
| DE69713513T2 (de) | 1996-09-25 | 2002-10-31 | Weston Medical Ltd., Stradbroke Eye | Verfahren und vorrichtung zur herstellung von gegenständen aus verformbarem material |
| US6258059B1 (en) | 1997-02-06 | 2001-07-10 | Weston Medical Limited | Injection aid |
| US6179583B1 (en) | 1997-02-25 | 2001-01-30 | Weston Medical Limited | Metered fluid delivery device |
| GB9818110D0 (en) * | 1998-08-19 | 1998-10-14 | Weston Medical Ltd | Needleless injectors and other devices |
| US20050027239A1 (en) | 1999-08-20 | 2005-02-03 | Stout Richard R. | Intradermal injection system for injecting DNA-based injectables into humans |
| KR20030071780A (ko) | 2000-11-30 | 2003-09-06 | 바이오밸브 테크놀로지스, 인코포레이티드 | 주입기 |
| DE10129583A1 (de) | 2001-06-20 | 2003-01-09 | Disetronic Licensing Ag | Vorrichtung und Verfahren zu Injektion |
| JP4234676B2 (ja) | 2002-07-11 | 2009-03-04 | テクファーマ・ライセンシング・アクチェンゲゼルシャフト | 皮内及び皮下注射装置 |
| US20060258986A1 (en) * | 2005-02-11 | 2006-11-16 | Hunter Ian W | Controlled needle-free transport |
| US20070055199A1 (en) | 2005-08-10 | 2007-03-08 | Gilbert Scott J | Drug delivery device for buccal and aural applications and other areas of the body difficult to access |
| EP1976581A1 (en) | 2006-01-23 | 2008-10-08 | Yoshio Oyama | An ampoule usable as a syringe and a syringe unit comprising the ampoule |
| FR2903908B1 (fr) * | 2006-07-18 | 2009-02-27 | Crossject Sa | Dispositif d'injection sans aiguille a double stoppeur a profils de pression abaisses |
| CA2666755C (en) * | 2006-09-01 | 2014-03-25 | Massachusetts Institute Of Technology | Needle-free injector device with autoloading capability |
| CN201342161Y (zh) * | 2009-01-10 | 2009-11-11 | 陈凯 | 一种由激光驱动的微喷射装置 |
| CN201361320Y (zh) * | 2009-02-26 | 2009-12-16 | 陈凯 | 用于液体喷射注射的推射装置 |
| US8734384B2 (en) * | 2010-09-15 | 2014-05-27 | Zogenix, Inc. | Needle-free injectors and design parameters thereof that optimize injection performance |
-
2011
- 2011-09-14 US US13/232,820 patent/US8734384B2/en not_active Expired - Fee Related
- 2011-09-14 CN CN201510167794.5A patent/CN104958813A/zh active Pending
- 2011-09-14 WO PCT/US2011/051617 patent/WO2012037268A2/en not_active Ceased
- 2011-09-14 AU AU2011302072A patent/AU2011302072B2/en not_active Ceased
- 2011-09-14 JP JP2013529302A patent/JP5856621B2/ja not_active Expired - Fee Related
- 2011-09-14 EP EP11825883.9A patent/EP2616123A4/en not_active Withdrawn
- 2011-09-14 CN CN201180044022.2A patent/CN103153370B/zh not_active Expired - Fee Related
- 2011-09-14 CA CA2810078A patent/CA2810078A1/en not_active Abandoned
-
2014
- 2014-04-14 US US14/251,959 patent/US9265888B2/en not_active Expired - Fee Related
-
2015
- 2015-12-11 JP JP2015241941A patent/JP6113260B2/ja not_active Expired - Fee Related
-
2016
- 2016-01-15 US US14/996,977 patent/US9662449B2/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1399567A (zh) * | 1999-08-20 | 2003-02-26 | 生物项目股份有限公司 | 将dna为主剂的注射剂注入人体的皮内注射系统 |
| US20080119783A1 (en) * | 2001-10-24 | 2008-05-22 | Zogenix, Inc. | Needleless injector |
| CN1681546A (zh) * | 2002-07-11 | 2005-10-12 | 特克法马许可公司 | 无针式注射装置 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105448172A (zh) * | 2015-12-30 | 2016-03-30 | 天津天堰科技股份有限公司 | 教学用模拟注射器 |
| CN110292684A (zh) * | 2019-08-09 | 2019-10-01 | 江苏丞宇米特医疗科技有限公司 | 一次装药多次注射双压力无针注射器 |
| CN113318301A (zh) * | 2021-06-28 | 2021-08-31 | 北京科技大学 | 一种大剂量多孔无针注射器 |
| CN115068747A (zh) * | 2022-07-21 | 2022-09-20 | 汤小彬 | 一种气压式无针注射手柄 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2616123A4 (en) | 2014-11-26 |
| AU2011302072B2 (en) | 2014-05-15 |
| CN103153370A (zh) | 2013-06-12 |
| CA2810078A1 (en) | 2012-03-22 |
| US20120065615A1 (en) | 2012-03-15 |
| JP5856621B2 (ja) | 2016-02-10 |
| WO2012037268A2 (en) | 2012-03-22 |
| US9265888B2 (en) | 2016-02-23 |
| WO2012037268A3 (en) | 2013-05-30 |
| JP2016052595A (ja) | 2016-04-14 |
| AU2011302072A1 (en) | 2013-03-28 |
| US20160129191A1 (en) | 2016-05-12 |
| US9662449B2 (en) | 2017-05-30 |
| CN103153370B (zh) | 2015-05-13 |
| JP2013540488A (ja) | 2013-11-07 |
| US8734384B2 (en) | 2014-05-27 |
| EP2616123A2 (en) | 2013-07-24 |
| JP6113260B2 (ja) | 2017-04-12 |
| US20140221915A1 (en) | 2014-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104958813A (zh) | 无针注射器和优化注射性能的无针注射器设计参数 | |
| AU2012205735B2 (en) | Needle free injectors | |
| Kale et al. | Needle free injection technology-An overview | |
| Crichton et al. | The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine | |
| CN1225293C (zh) | 用于将液态药物皮内注射到人体的系统 | |
| CN103071209A (zh) | 用无针注射递送粘稠制剂 | |
| Patwekar et al. | Needle free injection system: A review | |
| WO2017115867A1 (ja) | 投与装置の設計システム、投与システム、投与装置の設計方法、投与装置の設計プログラム、及び医療装置の設計システム | |
| US20170065771A1 (en) | Piston closures for drug delivery capsules | |
| Vadlapatla et al. | Needle-free injectors | |
| Attarde et al. | Needleless Injection System: An Overview | |
| AU2013203986B2 (en) | Improved Needle Free Injectors | |
| Raghuveer et al. | REVIEW ON NEEDLE FREE DRUG DELIVERY SYSTEM | |
| Rahman et al. | Comparative Studies of N Needle I | |
| Labu | Comparative Studies of Needle Free Injection Systems and Hypodermic Needle Injection: A Global Perspective | |
| WO2016137665A1 (en) | Needle-free injectors comprising sound suppression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151007 |
|
| WD01 | Invention patent application deemed withdrawn after publication |